Metabolic Shifts in Immunity and Inflammation
暂无分享,去创建一个
[1] L. Obeid,et al. Sphingosine Kinase 1 Is Up-regulated during Hypoxia in U87MG Glioma Cells ROLE OF HYPOXIA-INDUCIBLE FACTORS 1 AND 2 * , 2020 .
[2] S. Offenbacher,et al. Alteration of PTGS2 Promoter Methylation in Chronic Periodontitis , 2010, Journal of dental research.
[3] J. Penn,et al. Role of cytosolic phospholipase A(2) in retinal neovascularization. , 2010, Investigative ophthalmology & visual science.
[4] W. Hörl,et al. The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] M. Perretti,et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.
[6] S. Colgan,et al. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation , 2009, Expert opinion on therapeutic targets.
[7] J. O’Sullivan,et al. Generation of an epigenetic signature by chronic hypoxia in prostate cells. , 2009, Human molecular genetics.
[8] V. Nizet,et al. Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.
[9] Greg M. Delgoffe,et al. mTOR: taking cues from the immune microenvironment , 2009, Immunology.
[10] J. Karliner,et al. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. , 2009, American journal of physiology. Heart and circulatory physiology.
[11] R. Ahmed,et al. mTOR regulates memory CD8 T cell differentiation , 2009, Nature.
[12] S. Colgan,et al. Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis 1 , 2009, The Journal of Immunology.
[13] G. Semenza,et al. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. , 2009, Physiology.
[14] Wei Li,et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis , 2009, Proceedings of the National Academy of Sciences.
[15] Jie Zhou,et al. Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells , 2009, Molecular Cancer Research.
[16] C. Serhan,et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.
[17] Jens Vilstrup Johansen,et al. The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF* , 2008, Journal of Biological Chemistry.
[18] P. Ratcliffe,et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. , 2008, The Biochemical journal.
[19] Dan Yang,et al. A2B adenosine receptor gene deletion attenuates murine colitis. , 2008, Gastroenterology.
[20] K. Seeger,et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. , 2008, Biochemical and biophysical research communications.
[21] K. Morimura,et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. , 2008, Gastroenterology.
[22] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[23] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[24] T. Kuijpers,et al. Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex Organisation , 2008, PloS one.
[25] S. Colgan,et al. Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition , 2008 .
[26] E. Cummins,et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. , 2008, Gastroenterology.
[27] T. Veenstra,et al. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.
[28] C. Taylor,et al. Hypoxia and gastrointestinal disease , 2007, Journal of Molecular Medicine.
[29] S. Gay,et al. Epigenetics in inflammatory rheumatic diseases. , 2007, Arthritis and rheumatism.
[30] G. Natoli,et al. The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.
[31] I. Filimonov,et al. Molecular oxygen (a substrate of the cyclooxygenase reaction) in the kinetic mechanism of the bifunctional enzyme prostaglandin-H-synthase , 2007, Biochemistry (Moscow).
[32] Simmie L. Foster,et al. Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.
[33] L. Sowers,et al. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. , 2007, Cancer research.
[34] Brian R. Lawson,et al. Inhibition of Transmethylation Down-Regulates CD4 T Cell Activation and Curtails Development of Autoimmunity in a Model System , 2007, The Journal of Immunology.
[35] P. Ratcliffe. HIF-1 and HIF-2: working alone or together in hypoxia? , 2007, The Journal of clinical investigation.
[36] G. Burnstock,et al. Purine and pyrimidine receptors , 2007, Cellular and Molecular Life Sciences.
[37] Xuexian O Yang,et al. Chromatin Remodeling of Interleukin-17 (IL-17)-IL-17F Cytokine Gene Locus during Inflammatory Helper T Cell Differentiation* , 2007, Journal of Biological Chemistry.
[38] S. Colgan,et al. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. , 2007, The Journal of clinical investigation.
[39] Anjana Rao,et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells , 2007, Nature Immunology.
[40] Edgar Schmitt,et al. Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.
[41] Courtney M. Lappas,et al. Cutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis1 , 2006, The Journal of Immunology.
[42] J. Sévigny,et al. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.
[43] 司履生. Cancer epigenetics , 2006 .
[44] Danny Reinberg,et al. Histone Lysine Demethylases and Their Impact on Epigenetics , 2006, Cell.
[45] Bogdan Tanasa,et al. Regulation of Th2 differentiation and Il4 locus accessibility. , 2006, Annual review of immunology.
[46] S. Colgan,et al. Physiological roles for ecto-5’-nucleotidase (CD73) , 2006, Purinergic Signalling.
[47] Craig B. Thompson,et al. Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.
[48] T. Spector,et al. Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] Jian-Ping Zuo,et al. Inhibition of S-Adenosyl-l-homocysteine Hydrolase Induces Immunosuppression , 2005, Journal of Pharmacology and Experimental Therapeutics.
[50] W. Reik,et al. Epigenetic reprogramming in mammals. , 2005, Human molecular genetics.
[51] M. Sitkovsky,et al. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. , 2005, Nature reviews. Immunology.
[52] P. Laird. Cancer epigenetics. , 2005, Human molecular genetics.
[53] John E Tomaszewski,et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. , 2004, The Journal of clinical investigation.
[54] C. Shelley,et al. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[55] Christopher J. Schofield,et al. Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.
[56] R. Bruick,et al. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. , 2003, Genes & development.
[57] P. Ratcliffe,et al. 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. , 2003, Bioorganic & medicinal chemistry letters.
[58] P. Ratcliffe,et al. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels , 2003, Journal of Cell Science.
[59] N. Abraham,et al. COX-2 lack of function in hypoxia-induced ocular surface inflammation. , 2003, Thrombosis research.
[60] P. Ratcliffe,et al. Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. , 2003, Bioorganic & medicinal chemistry letters.
[61] S. Reddy,et al. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[62] L. Poellinger,et al. Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells , 2003 .
[63] S. Reddy,et al. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Pollard,et al. Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.
[65] F. Lembeck,et al. Severe Hypoxia Inhibits Prostaglandin I2 Biosynthesis and Vasodilatory Responses Induced by Ionophore A23187 in the Isolated Rabbit Ear , 2002, Pharmacology.
[66] R. Bolli,et al. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. , 2002, Cardiovascular research.
[67] C. Thompson,et al. Homeostatic control of lymphocyte survival: potential origins and implications , 2002, Nature Immunology.
[68] D. Peet,et al. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.
[69] David I Stuart,et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. , 2002, Nature.
[70] P. Buttrick,et al. Inhibition of Collagen Synthesis With Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation After Myocardial Infarction , 2001, Circulation.
[71] S. McKnight,et al. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.
[72] G. Semenza,et al. HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus , 2001, Cell.
[73] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[74] M. Murakami,et al. Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2 * , 2001, The Journal of Biological Chemistry.
[75] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[76] D. Jacobsen,et al. Homocysteine in health and disease , 2001 .
[77] E. Conner,et al. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. , 2001, The Journal of pharmacology and experimental therapeutics.
[78] C. Clish,et al. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.
[79] L. Poellinger,et al. Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.
[80] A. Harris,et al. Macrophage responses to hypoxia: relevance to disease mechanisms , 1999, Journal of leukocyte biology.
[81] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[82] S. Yamamoto,et al. Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate. , 1999, Biochimica et biophysica acta.
[83] P. Chiang. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. , 1998, Pharmacology & therapeutics.
[84] L. Wartman,et al. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. , 1998, Gene expression.
[85] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[86] Y Fujii-Kuriyama,et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[87] V. Sexl,et al. Stimulation of the Mitogen-activated Protein Kinase via the A2A-Adenosine Receptor in Primary Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[88] M. Runge,et al. Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[89] S. Spiegel,et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.
[90] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[91] M. Guppy,et al. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. , 1994, The Journal of biological chemistry.
[92] G. Babcock,et al. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. , 1993, Cellular immunology.
[93] J. Remacle,et al. Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. , 1993, The American journal of physiology.
[94] R. Baldessarini. Neuropharmacology of S-adenosyl-L-methionine. , 1987, The American journal of medicine.
[95] I. Marks,et al. Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer. , 1987, The American journal of medicine.
[96] T. Herlin,et al. Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.
[97] B. Babior,et al. Effects of oxygen tension and pH on the respiratory burst of human neutrophils. , 1979, Blood.